Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-30 Purchase |
2021-08-31 4:31 pm |
ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer |
15,000 | $3.429 | $51,435 | 32,613 (Direct) |
View |
| 2021-08-20 Purchase |
2021-08-24 08:59 am |
ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer |
15,000 | $3.219 | $48,285 | 17,613 (Direct) |
View |
| 2021-06-16 Sale |
2021-06-22 08:58 am |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Boyd Steven 10% Owner |
2,303,469 | $6.1778 | $14,230,402 | 211,746 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-22 Option Award |
2021-09-17 6:07 pm |
N/A N/A |
ReShape Lifesciences Inc. | RSLS | McDougal Lori Courtney Director |
253,429 | $0 | 253,429 (Direct) |
View |
| 2021-06-28 Exercise |
2021-06-29 9:44 pm |
N/A N/A |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Boyd Steven 10% Owner |
7,130,806 | $0 | 14,446,692 (Direct) |
View |
Ownership |
2021-06-24 5:29 pm |
N/A N/A |
ReShape Lifesciences Inc. | RSLS | STANKOVICH THOMAS Chief Financial Officer |
0 | $0 | 2,613 (Direct) |
View |
Ownership |
2021-06-22 08:49 am |
N/A N/A |
ReShape Lifesciences Inc. | RSLS | ARMISTICE CAPITAL LLC Boyd Steven 10% Owner |
0 | $0 | 19,862,962 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 7:48 pm |
N/A 2030-09-16 |
OBALON THERAPEUTICS INC | OBLN | Fisher Douglas Director |
54,500 | $0 | 54,500 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 7:47 pm |
N/A 2030-09-16 |
OBALON THERAPEUTICS INC | OBLN | Stevenson Sharon Director |
54,500 | $0 | 54,500 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 7:45 pm |
N/A 2030-09-16 |
OBALON THERAPEUTICS INC | OBLN | HOWE LESLEY H Director |
54,500 | $0 | 54,500 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 7:44 pm |
N/A 2030-09-16 |
OBALON THERAPEUTICS INC | OBLN | DITTAMORE RAYMOND V Director |
54,500 | $0 | 54,500 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 7:44 pm |
N/A 2030-09-16 |
OBALON THERAPEUTICS INC | OBLN | Plovanic William J. Director |
54,500 | $0 | 54,500 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 7:43 pm |
N/A 2030-09-16 |
OBALON THERAPEUTICS INC | OBLN | Kamdar Kim P. Director |
54,500 | $0 | 54,500 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-25 6:56 pm |
N/A 2030-06-23 |
OBALON THERAPEUTICS INC | OBLN | Hussainy Nooshin Chief Financial Officer |
218,000 | $0 | 218,000 (Direct) |
View |
| 2020-06-23 Option Award |
2020-06-25 6:56 pm |
N/A 2030-06-23 |
OBALON THERAPEUTICS INC | OBLN | Rasdal Andrew P President, CEO & Exec Chairman |
218,000 | $0 | 218,000 (Direct) |
View |